Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin

Author： Foster Shonda A.   Whangbo Albert   Mitchell Beth   Muram David   Mershon John L.   Kar Rishi   Vedarajan Ganesh  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.11, 2010-11, pp. : 2521-2526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates in breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 4, 2015-08 ,pp. : 753-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

DIAGNOSTIC SCREENING PROCEDURES FOR THE OFFICE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 3, Iss. 10, 1955-10 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bisphosphonates as adjuvant therapy for breast cancer

By Burkinshaw Roger   Coleman Robert  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 115-126

Future Medicine

Access to resources Recommend Favorite

Performance characteristics of the MammaPrint® breast cancer diagnostic gene signature

By Delahaye Leonie JM   Wehkamp Diederik   Floore Arno N   Bernards Rene   van‘t Veer Laura J   Glas Annuska M  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 801-811

Future Medicine

Access to resources Recommend Favorite

Patient Factors Associated with Breast Cancer Screening Among Older Women

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 10, 1996-10 ,pp. : 1210-1214

John Wiley & Sons Inc

Access to resources Recommend Favorite